CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 126 enrolled
Drug / intervention
Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02937623
NCT02937623N/ACompleted

A Proof-of-principle Clinical Study Investigating the Efficacy of a Dissolvable Strip in Providing Rapid Relief From Dentinal Hypersensitivity.

GlaxoSmithKline·interventional·Posted Oct 18, 2016·Updated Jan 29, 2018

In Brief

A clinical study evaluating Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate) for Dentin Sensitivity. Completed, enrolled 126 participants across 1 site.

Detailed Summary

A proof of principle single-centre, randomized-controlled, examiner-blind, two treatment group study to investigate the efficacy of an experimental 15% w/w dissolvable strip in relieving dentine hypersensitivity (DH) after a single application and up to 4 hours after application compared to no treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 18, 2016
Enrollment StartNov 21, 2016
Primary CompletionDec 22, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.7 years ago

Interventions

Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate)device

Experimental dissolvable polymer strip containing Novamin (15% weight by weight\[w/w\] calcium sodium phosphosilicate).